Theoretical and Experimental Approach for the Sensation of Urine Ubiquitin Conjugating Enzyme E2 C (UBE2C) mRNA Related to Bladder Cancer by Polyacrylamide Sensor Doped with Zinc Oxide
DOI:
https://doi.org/10.48048/tis.2023.3566Keywords:
Biosensor, Bladder cancer, Modeling, FTIR, Polyacrylamide, ZnO nanoparticle, Cysteine 114, UBE2CAbstract
Bladder cancer (BC) is the ninth and 4 most prevalent cancer in men worldwide and in the United States. Urothelial carcinoma (UC) is the most common histological kind. Biosensors are devices that translate complex biological events into an electrical signal whose intensity is proportional to the analyte’s concentration, allowing them to detect a specific biological analyte. The nanotechnology with nanoparticles improves and modifies the biorecognition element to improve the biosensing phenomenon, making it one of the most popular subjects among scientists. Employment of ZincOxide (ZnO) nanoparticles into the polyacrylamide (PAM) is supposed to enhance electrical and sensory capabilities that promise more inventive and faster detection with improved repeatability.
Studying the ability of PAM\ZnO nanocomposite to sense Urine Ubiquitin Conjugating Enzyme E2 C (UBE2C), the nanocomposite’s interactions with the enzyme was studied using a modeling model, and then the PAM\ZnO nanocomposite was prepared and studied with spectroscopic technique. Consequently, the Fourier Transform Infrared (FTIR) spectra for PAM\ZnO resulted in peaks in the 400 - 600 cm−1 range that vanished in acidic media.
Density functional theory (DFT) calculations were performed at B3LYPL using the basis set 6-31G on PAM\ZnO nanocomposites with cysteine 114. The findings of the HOMO/LUMO bandgap energy, total dipole moment (TDM), and Molecular Electrostatic Potential (MESP) indicated that the effect of ZnO in the presence of PAM gives a nanocomposite with high electronic characteristics with a TDM ranging from 5.4464 to 12.3348 Debye, and bandgap (∆E) 0.19965 to 0.28302 eV. A variation in the electrostatic characteristics of this composite followed the addition of Cystine 114. The distinctive properties of such nanocomposite PAM/ZnO enable usage in biosensor applications for bladder cancer. Finally, the FTIR spectrum showed that the estimated model fits as a proper biosensor.
HIGHLIGHTS
- Mapping molecular electrostatic potential (MESP) maps reveal important details about the interaction, active sites, and the type of chemical addition that a molecule is most likely to go through
- Theoretical studies show that combining ZnO with PAM polymer is feasible, as it indicates the production of more reactive structures
- In terms of performance, after adding Cystine114 to PAM/ZnO polymer, electrostatics characteristics of PAM/ZnO polymer varied in acidic medium, which indicates the potentiality of the constructed Polyacrylamide sensor modified with Zinc oxide for bladder cancer
GRAPHICAL ABSTRACT 
Downloads
Metrics
References
SJ Crabb and J Douglas. The latest treatment options for bladder cancer. Br. Med. Bull. 2018; 128, 85-95.
J Husband, J Olliff, MP Williams, C Heron and GR Cherryman. Bladder cancer: Staging with CT and MR imaging. Radiology 1989; 173, 435-40.
JJ Underwood, RS Quadri, SP Kalva, H Shah, AR Sanjeevaiah, MS Beg and PD Sutphin. Liquid biopsy for cancer: Review and implications for the radiologist. Radiology 2020; 294, 5-17.
J Marrugo-Ramírez, M Mir and J Samitier. Blood-based cancer biomarkers in liquid biopsy: A promising non-invasive alternative to tissue biopsy. Int. J. Mol. Sci. 2018; 19, 2877.
I Lodewijk, M Dueñas, C Rubio, E Munera-Maravilla, C Segovia, A Bernardini, A Teijeira, JM Paramio and C Suárez-Cabrera. Liquid biopsy biomarkers in bladder cancer: A current need for patient diagnosis and monitoring. Int. J. Mol. Sci. 2018; 19, 2514.
X Min, Y Zhuang, Z Zhang, Y Jia, A Hakeem, F Zheng, Y Cheng, BZ Tang, X Lou and F Xia. Lab in a tube: Sensitive detection of MicroRNAs in urine samples from bladder cancer patients using a single-label DNA probe with AIEgens. ACS Appl. Mater. Interfac. 2015; 7, 16813-8.
XM Piao, EJ Cha, SJ Yun and WJ Kim. Role of exosomal miRNA in bladder cancer: A promising liquid biopsy biomarker. Int. J. Mol. Sci. 2021; 22, 1713.
AI Nossier, S Eissa, MF Ismail, MA Hamdy and HMES Azzazy. Direct detection of hyaluronidase in urine using cationic gold nanoparticles: A potential diagnostic test for bladder cancer. Biosens. Bioelectron. 2014; 54, 7-14.
S Eissa, SM Shawky, M Matboli, S Mohamed and HM Azzazy. Direct detection of unamplified hepatoma upregulated protein RNA in urine using gold nanoparticles for bladder cancer diagnosis. Clin. Biochem. 2014; 47, 104-10.
Y Xu, C Luo, J Wang, L Chen, J Chen, T Chen and Q Zeng. Application of nanotechnology in the diagnosis and treatment of bladder cancer. J. Nanobiotechnol. 2021; 19, 393.
SK Patel, J Parmar, V Sorathiya, TK Nguyen and V Dhasarathan. Tunable infrared metamaterial-based biosensor for detection of hemoglobin and urine using phase change material. Sci. Rep. 2021; 11, 7101.
JW Rasmussen, E Martinez, P Louka and DG Wingett. Zinc oxide nanoparticles for selective destruction of tumor cells and potential for drug delivery applications. Expet. Opin. Drug Deliv. 2010; 7, 1063-77.
HFE Sharif, F Giosia and SM Reddy. Investigation of polyacrylamide hydrogel‐based molecularly imprinted polymers using protein gel electrophoresis. J. Mol. Recogn. 2022; 35, e2942.
M Ogiso, N Minoura, T Shinbo and T Shimizu. DNA detection system using molecularly imprinted polymer as the gel matrix in electrophoresis. Biosens. Bioelectron. 2007; 22, 1974-81.
G Selvolini and G Marrazza. MIP-based sensors: Promising new tools for cancer biomarker determination. Sensors 2017; 17, 718.
Y Wang, M Hana, G Liu, X Hou, Y Huang, K Wu and C Li. Molecularly imprinted electrochemical sensing interface based on in-situ-polymerization of amino-functionalized ionic liquid for specific recognition of bovine serum albumin. Biosens. Bioelectron. 2015; 74, 792-8.
CP Chou, NC Huang, SJ Jhuang, HB Pan, NJ Peng, JT Cheng, CF Chen, JJ Chen and TH Chang. Ubiquitin-conjugating enzyme UBE2C is highly expressed in breast microcalcification lesions. PLoS One 2014; 9, e93934.
A Mbeutcha, I Lucca, R Mathieu, Y Lotan and SF Shariat. Current status of urinary biomarkers for detection and surveillance of bladder cancer. Urol. Clin. 2016; 43, 47-62.
A Aftab, A Ismail, S Khokhar and ZH Ibupoto. Novel zinc oxide nanoparticles deposited acrylamide composite used for enhancing the performance of water-based drilling fluids at elevated temperature conditions. J. Petrol. Sci. Eng. 2016; 146, 1142-57.
H Elhaes, M Morsy, I Yahia and M Ibrahim. Molecular modeling analyses for electronic properties of CNT/TiO2 nanocomposites. Opt. Quant. Electron. 2021; 53, 269.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Walailak University
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
